Investor dismay has driven shares of Biogen down 30.7% over the past six months.
This coming week, Biogen will have a shot at redemption. By Wednesday, the Centers for Medicare and Medicaid Services, which manages the Medicare program, is scheduled to issue proposed guidelines that would determine whether and how Medicare will cover Aduhelm.
The process comes amid skepticism from doctors over the drug’s efficacy. Medicare coverage is essential to the commercial future of Aduhelm, given that the majority of Alzheimer’s patients in the U.S. are on Medicare.
The proposed guidelines won’t be completed until April, but what comes next week will give investors a clue as to how CMS is leaning. Possibilities range from full coverage to no coverage, with some options in between.
Even proposed guidelines that are positive for Biogen won’t erase investor worries. “The market may need time to see sales ramp,” Jefferies analyst Michael Yee recently wrote. A generally positive outcome next week could lift Biogen shares by 5% to 15%, he said, while a generally negative outcome could push shares down by 10% to 20%.
The proposed guidelines would apply not only to Aduhelm, but also to similar drugs that could be approved in the future, such as
Eli Lilly
របស់
donanemab.
សប្តាហ៍ក្រោយ
ថ្ងៃច័ន្ទ 1 / 10 ។
អ្នកផលិត Cannabis
Tilray
reports second-quarter fiscal-2022 results
ថ្ងៃអង្គារទី ១១/២១
Albertsons
holds a conference call to discuss earnings.
The Senate Banking Committee conducts a hearing to weigh the renomination of Jerome Powell as chairman of the Federal Reserve for another four-year term. Lael Brainard’s nomination as vice chair will be taken up by the same committee on Thursday, Jan. 13.
សហព័ន្ធជាតិ of Independent Business releases its Small Business Optimism Index for December. Consensus estimate is for a 99.5 reading, about one point more than November’s figure.
ថ្ងៃពុធ 1 / 12
ការិយាល័យការងារ Statistics reports the consumer price index for December. Economists forecast a 7.1% year-over-year spike, after a 6.8% rise in December, the fastest clip since 1982. The core CPI, which excludes volatile food and energy prices, is expected to jump 5.4%, half a percentage point more than in November, which was the most since 1991. Inflation has become a chief concern on both Main Street and Wall Street as the Federal Reserve has acknowledged that it isn’t transitory.
សហព័ន្ធបម្រុង releases the beige book for the first of eight times this year. The report gathers anecdotal information and summarizes current economic conditions from the 12 Federal Reserve districts.
ថ្ងៃព្រហស្បតិ៍ 1 / 13
ដីសណ្តរបន្ទាត់អ៊ែរ
និង
តៃវ៉ាន់ផលិតគ្រឿងបន្លាស់
រៀបចំការធ្វើសន្និសីទដើម្បីពិភាក្សាអំពីលទ្ធផលប្រចាំត្រីមាស។
របាយការណ៍របស់ BLS the producer price index for December. Consensus estimate is for a 0.4% monthly gain, while the core PPI is seen increasing 0.5%. This compares with rises of 0.8% and 0.7%, respectively, in November.
មន្ទីរការងារ reports initial jobless claims for the week ending on Jan. 8. In the first week of December, jobless claims were below 190,000, a level not seen in more than half a century.
ថ្ងៃសុក្រ 1 / 14
Fourth-quarter earnings season begins in earnest with three of the largest U.S. banks reporting earnings.
JPMorgan Chase
,
Wells Fargo
,
និង
ក្រុមហ៊ុន Citigroup
all release their results before the opening bell.
BlackRock
និង
ធនាគារសាធារណរដ្ឋទីមួយ
បញ្ចេញប្រាក់ចំណូល។
សាកលវិទ្យាល័យ Michigan releases its Consumer Sentiment index for January. Expectations are for a 70.4 reading, roughly even with the December data. The index is about 20% lower than its postpandemic peak in April, in part due to consumers’ concerns about rising prices and cost of housing.
ការិយាល័យជំរឿន reports retail sales data for December. Economists forecast a 0.3% month-over-month bump for consumer spending. Excluding autos, spending is also seen ticking up 0.3%. This would match the November data for both releases.
សរសេរទៅកាន់ Josh Nathan-Kazis នៅ [អ៊ីមែលការពារ]
